Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Inquiry Memorial
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
Support and FAQs
NHS Psychological Support
Support Groups
Infected Blood Support Schemes
Hepatitis C Testing
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Annual Returns were produced for The Royal London Haemophilia Centre for 1981.
Published on:
27 September, 2024
Annual Returns were produced for The Royal London Haemophilia Centre for 1982.
Published on:
27 September, 2024
Annual Returns were produced for the Lewisham Haemophilia Centre for 1981.
Published on:
27 September, 2024
Annual Returns were produced for the Lewisham Haemophilia Centre for 1982.
Published on:
27 September, 2024
In 1981 and 1982 Haemophilia A patients were primarily treated with commercial concentrate, Annual Returns for Royal Manchester Children's Hospital 1982
Published on:
27 September, 2024
There was no policy of restricting patients to single manufacturers or batches of commercial concentrate. Annual Returns for Royal Manchester Children's Hospital 1982
Published on:
27 September, 2024
Annual Returns were produced for the Cambridge Haemophilia Centre for 1980.
Published on:
27 September, 2024
Annual Returns were produced for the Cambridge Haemophilia Centre for 1981.
Published on:
27 September, 2024
Annual Returns were produced for the Cambridge Haemophilia Centre for 1982.
Published on:
27 September, 2024
Annual Returns were produced for the Coventry Haemophilia Centre for 1980.
Published on:
27 September, 2024
Annual Returns were produced for the Coventry Haemophilia Centre for 1981.
Published on:
27 September, 2024
Annual Returns were produced for the Coventry Haemophilia Centre for 1982.
Published on:
27 September, 2024
Annual Returns for the Kent Haemophilia Centre were produced for 1980.
Published on:
27 September, 2024
Annual Returns for the Kent Haemophilia Centre were produced for 1981.
Published on:
27 September, 2024
Annual Returns for the Kent Haemophilia Centre were produced for 1982.
Published on:
27 September, 2024
It was realised that while factor VIII continued to be imported the potential existed for infections in the UK haemophilia population even more serious than hepatitis.
Published on:
27 September, 2024
The precise number of children infected with HIV as a consequence of their treatment at Alder Hey was unclear with a July 1987 report recording 16 cases.
Published on:
30 September, 2024
In 1977 Birmingham Children's Hospital treated its Haemophilia A patients predominantly with cryoprecipitate together with some commercial concentrate. No NHS Factor 8 was used that year.
Published on:
30 September, 2024
Annual Returns for Birmingham Children's Hospital 1978 showed Factor 8 concentrate outstripped cryoprecipitate, with more commercial concentrate being used than NHS. The use of cryoprecipitate had reduced substantially from the previous year.
Published on:
30 September, 2024
Annual Returns for Birmingham Children's Hospital 1979 showed commercial concentrate usage in 1979 was almost double that of 1978.
Published on:
30 September, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2266
Page
2267
Page
2268
Page
2269
Current page
2270
Page
2271
Page
2272
Page
2273
Page
2274
…
Next page
Next
Last page
Last